Phosphoinositide-Dependent Signaling in Cancer: A Focus on Phospholipase C Isozymes

Eric Owusu Obeng1, Isabella Rusciano1, Maria Vittoria Marvi1

  • 1Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.

Insights

Phosphoinositide-specific phospholipase C (PLC) enzymes are crucial in cancer, regulating cell survival and proliferation. This review details PLC involvement in various cancer types, focusing on PLCβ, PLCγ, PLCδ, and PLCε isoforms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Phosphoinositides (PI) are minor cell components but critical in cancer progression.
  • Specific PIs like PtdIns(3,4,5)P3 and PtdIns(4,5)P2 regulate key cancer cell behaviors.
  • Phosphoinositide-specific phospholipase C (PLC) enzymes hydrolyze PtdIns(4,5)P2, generating second messengers.

Purpose of the Study:

  • To review the current understanding of phosphoinositide-specific phospholipase C (PLC) involvement in cancer.
  • To highlight the roles of PLCβ, PLCγ, PLCδ, and PLCε isoforms in oncogenesis.

Main Methods:

  • Literature review of studies on PLC isoforms and their functions in cancer.
  • Analysis of evidence linking PLC activity to cancer cell survival, proliferation, invasion, and growth.

Main Results:

  • Diacylglycerol (DAG) and inositol 1,4,5 trisphosphate (InsP3) produced by PLC regulate Protein Kinase C (PKC) and calcium release.
  • These signaling events are implicated in numerous biological processes vital to cancer.
  • Specific PLC isoforms (PLCβ, PLCγ, PLCδ, PLCε) show significant involvement across various cancer types.

Conclusions:

  • Phosphoinositide-specific phospholipase C enzymes play multifaceted roles in cancer development and progression.
  • Further research is needed to fully elucidate the regulatory mechanisms of PLCs in oncogenic processes.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
9.9K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
14.0K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.7K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
8.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K